Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALAB NASDAQ:ALAB NASDAQ:HCP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALABAstera Labs$240.37+3.9%$157.95$44.40▼$240.80$40.03B1.464.95 million shs3.08 million shsALABAstera Labs$240.37+3.9%$157.95$44.40▼$240.80$40.03B1.464.95 million shs3.08 million shsHCPHashiCorp$34.78$34.78$33.11▼$34.85$7.11B1.182.44 million shsN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALABAstera Labs+0.78%+7.03%+24.45%+148.94%+432.31%ALABAstera Labs+0.78%+7.03%+24.45%+148.94%+432.31%HCPHashiCorp0.00%0.00%0.00%0.00%+2.78%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALABAstera Labs$240.37+3.9%$157.95$44.40▼$240.80$40.03B1.464.95 million shs3.08 million shsALABAstera Labs$240.37+3.9%$157.95$44.40▼$240.80$40.03B1.464.95 million shs3.08 million shsHCPHashiCorp$34.78$34.78$33.11▼$34.85$7.11B1.182.44 million shsN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALABAstera Labs+0.78%+7.03%+24.45%+148.94%+432.31%ALABAstera Labs+0.78%+7.03%+24.45%+148.94%+432.31%HCPHashiCorp0.00%0.00%0.00%0.00%+2.78%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALABAstera Labs 2.89Moderate Buy$142.00-40.93% DownsideALABAstera Labs 2.89Moderate Buy$142.00-40.93% DownsideHCPHashiCorp 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest ALAB, HCP, and ALAB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025ALABAstera LabsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$160.00 ➝ $200.009/2/2025ALABAstera LabsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$160.00 ➝ $200.008/29/2025ALABAstera LabsMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$155.00 ➝ $200.008/29/2025ALABAstera LabsMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$155.00 ➝ $200.008/29/2025ALABAstera LabsCICC ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$190.008/29/2025ALABAstera LabsCICC ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$190.008/12/2025ALABAstera LabsZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy8/12/2025ALABAstera LabsZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy8/7/2025ALABAstera LabsBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$75.00 ➝ $155.008/7/2025ALABAstera LabsBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$75.00 ➝ $155.008/7/2025ALABAstera LabsSusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$80.00 ➝ $125.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALABAstera Labs$396.29M100.82N/AN/A$6.08 per share39.54ALABAstera Labs$396.29M100.82N/AN/A$6.08 per share39.54HCPHashiCorp$654.89M10.86N/AN/A$6.09 per share5.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALABAstera Labs-$83.42M$0.56430.01324.835.8216.54%9.53%8.67%11/3/2025 (Estimated)ALABAstera Labs-$83.42M$0.56430.01324.835.8216.54%9.53%8.67%11/3/2025 (Estimated)HCPHashiCorp-$190.67M-$0.61N/AN/AN/A-18.66%-7.91%-5.79%N/ALatest ALAB, HCP, and ALAB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025ALABAstera Labs$0.33$0.44+$0.11$0.29$172.46 million$191.93 million8/5/2025Q2 2025ALABAstera Labs$0.33$0.44+$0.11$0.29$172.46 million$191.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALABAstera LabsN/AN/AN/AN/AN/AALABAstera LabsN/AN/AN/AN/AN/AHCPHashiCorp$1.484.26%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALABAstera LabsN/A11.1010.55ALABAstera LabsN/A11.1010.55HCPHashiCorpN/A3.793.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALABAstera Labs60.47%ALABAstera Labs60.47%HCPHashiCorp86.25%Insider OwnershipCompanyInsider OwnershipALABAstera Labs12.50%ALABAstera Labs12.50%HCPHashiCorp22.49%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALABAstera Labs225166.22 million145.44 millionOptionableALABAstera Labs225166.22 million145.44 millionOptionableHCPHashiCorp1,850204.45 million158.47 millionOptionableALAB, HCP, and ALAB HeadlinesRecent News About These CompaniesHCP Terraform Now Offers Hold Your Own Key (HYOK) Option for Artifact EncryptionAugust 18, 2025 | infoq.comITelix Pharmaceuticals’ Gozellix Secures Permanent HCPCS CodeJuly 8, 2025 | tipranks.comHashiCorp speaks up about adjusting to life under IBMJune 5, 2025 | msn.comIBM acquires HashiCorp: Terraform and Ansible to work togetherJune 3, 2025 | heise.deHHashiCorp Expands Unified Lifecycle Management for Hybrid Cloud OperationsJune 3, 2025 | globenewswire.comHashiCorp Releases Terraform MCP Server for AI IntegrationMay 23, 2025 | infoq.comIHow Terraform is evolving infrastructure as codeMarch 31, 2025 | infoworld.comIDexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type ...March 19, 2025 | gurufocus.comVeeva Systems Inc (VEEV) Launches Veeva CRM Pulse for Enhanced HCP Access DataMarch 4, 2025 | gurufocus.comHASHI Earnings Preview: Recent $HCP Insider Trading, Hedge Fund Activity, and MoreMarch 4, 2025 | quiverquant.comQHashiCorp Inc.March 2, 2025 | wsj.comGuru Fundamental Report for HCPMarch 1, 2025 | nasdaq.comM&A News: IBM Finally Closes $6.4B HashiCorp DealFebruary 28, 2025 | markets.businessinsider.comIBM completes $6.4B HashiCorp acquisition following regulatory approvalsFebruary 27, 2025 | siliconangle.comSIBM closes $6.4B HashiCorp acquisitionFebruary 27, 2025 | techcrunch.comTKlick Health Announces New AI Workflow that Simulates HCPs to Transform Market Research for Life SciencesFebruary 26, 2025 | financialpost.comFKlick Health Announces New AI Workflow that Simulates HCPs to Transform Market Research for Life SciencesFebruary 26, 2025 | financialpost.comFCMA Clears IBM / HashiCorp DealFebruary 25, 2025 | marketwatch.comHashiCorp stock rises after UK regulator approves IBM mergerFebruary 25, 2025 | za.investing.comUK CMA clears IBM’s acquisition of HashiCorpFebruary 25, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALAB, HCP, and ALAB Company DescriptionsAstera Labs NASDAQ:ALAB$240.37 +9.08 (+3.93%) As of 03:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.Astera Labs NASDAQ:ALAB$240.37 +9.08 (+3.93%) As of 03:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.HashiCorp NASDAQ:HCPHashiCorp, Inc. engages in the provision of multi-cloud infrastructure automation solutions worldwide. The company offers infrastructure provisioning products, including Terraform, that enables IT operations teams to apply an Infrastructure-as-Code approach, where processes and configuration required to support applications are codified and automated instead of being manual and ticket-based; Packer, that provides a consistent way to define the process of transforming the raw source inputs into a production worthy artifact, across any environment or packaging format; and Vagrant, that allows teams to define how development environments are set up. It also provides security products, such as Vault, a secrets management and data protection product, which enables security teams to apply policies based on application and user identity to govern access to credentials and secure sensitive data; and Boundary, that applies an identity-based approach to privileged access management and unifies the controls to a single system. In addition, the company offers Consul, an application-centric networking automation product that enables practitioners to manage application traffic, security teams to secure and restrict access between applications, and operations teams to automate the underlying network infrastructure; Nomad, a scheduler and workload orchestrator, which provides practitioners with a self-service interface to manage the application lifecycle; and Waypoint, an application delivery product that provides a developer-focused workflow for the build, deploy, and release process. Further, it provides HashiCorp Cloud Platform, a fully-managed cloud platform for multiple products to accelerate enterprise cloud migration by addressing resource and skills gaps, improving operational efficiency, and speeding up deployment time for customers. The company was incorporated in 2012 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Reddit Hits Record Highs: Why Wall Street Is Taking Notice Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
